Bottom line
What is RMLAX's expense ratio?
RMLAX's expense ratio is 1.04%, or about $104 a year on every $10,000 invested. That is more expensive than 62% of allocation / balanced funds we track (median 0.91%). This share class also charges a front-end sales load of up to 5.75%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Feb 27, 2026
RMLAX fee table
| Net expense ratio | 1.04% |
|---|---|
| Gross expense ratio | 1.36% |
| Management fee | 0.17% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.4% |
| Acquired fund fees | 0.54% |
| Fee waiver / reimbursement | -0.32% |
| Max front-end sales load | 5.75% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Feb 27, 2026
What RMLAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| RMLAX | $675 | $951 | $1,248 | $2,090 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.04% expense ratio costs roughly $57,400 in lost growth, versus about $50,800 for the median allocation / balanced fund (0.91%).